Konten bukti dipertahankan dalam bahasa Inggris.

Executive summary

Online supply of medicines can span multiple jurisdictions: the seller, website, payment service, dispatch point, and buyer need not be in the same country. INTERPOL and WHO sources document the resulting enforcement problem for illicit, substandard, and falsified medicines generally; they do not quantify peptide-specific supply chains.

The cross-border peptide business model

Patterns documented in online-medicine cases may include:

  1. a seller, hosting provider, payment service, and dispatch point in different jurisdictions;

  2. postal or courier fulfillment;

  3. product descriptions such as “research chemical” or “cosmetic ingredient”;

  4. disclaimers that may conflict with human-use claims elsewhere on a site.

These are risk patterns, not a census of peptide vendors. The atlas found no authoritative dataset establishing dominant source countries or prevalence.

Cross-border supply chain and controls
Cross-border supply chain and control pointsA six-stage online supply chain is intersected by seven public and private actors with different mandates and five distinct control points.national medicineregulatorINTERPOLWCOWHO mechanismUPUplatformdomain registrarseller /manufacturerwebsite /platformpaymentpostal /couriercustoms /import authorityrecipientjurisdictionclaimsfundsparcelborderlocal sale / use
Organizations have different mandates; appearance on the chain does not mean universal jurisdiction.
Alternatif teks
  • Chain: seller or manufacturer, website or platform, payment, postal or courier, customs or import authority, recipient jurisdiction.
  • Actors: national medicine regulator, INTERPOL, WCO, WHO mechanism, UPU, platform, and domain registrar.
  • Control points: claims, funds, parcel, border, and local sale or use.

International enforcement mechanisms

INTERPOL — Operation Pangea

Operation Pangea is an international action against online sale of illicit medicines and medical devices. Published reports describe seizures and online enforcement actions, but do not establish a peptide-specific targeting rate.

Source: https://www.interpol.int/en/Crimes/Illicit-goods/Pharmaceutical-crime-operations

World Customs Organization (WCO)

The WCO coordinates customs authorities worldwide. The WCO's Pharmaceutical Crime Programme provides training and tools to help customs officers in participating member states identify unapproved medicines in the postal and courier stream. Actual screening and interception rates vary by country.

WHO Member State Mechanism

The WHO Member State Mechanism on substandard and falsified medical products provides a global platform for information sharing on substandard and falsified medical products. Its landing page does not establish the status of any named peptide product.

Source: https://www.who.int/health-topics/substandard-and-falsified-medical-products

Universal Postal Union (UPU)

The UPU Postal Security Group and Customs Advisory Group develop standards for detecting illicit shipments in the postal stream, including medicinal products.

E-commerce platform responsibility

Marketplace, advertising, and storefront policies change and differ by country. A platform's current primary policy must be checked before making a claim about permitted listings or enforcement. No peptide-specific removal rate was verified for this atlas.

Payment processor restrictions

Payment services may restrict pharmaceutical transactions under their current terms and applicable law. This atlas did not verify peptide-specific account termination or fund-freeze statistics.

Domain name regulation

Domain registrars and ICANN's UDRP enable trademark owners to challenge domain names that infringe IP (e.g., "buyozempic.com" infringing the OZEMPIC trademark). WHOIS privacy regulations (GDPR in EU, similar laws elsewhere) can complicate identification of domain registrants, but law enforcement requests can bypass privacy shields.

Control-point comparison

Control pointActor named on pageWhat it can addressLimitation
Medicine classification and claimsNational medicine regulatorProduct status, therapeutic claims, advertising, and local supplyAuthority and legal test are jurisdiction-specific
Customs and parcel streamNational customs authorities, WCO, UPUBorder screening, customs cooperation, and postal-security standardsScreening and interception rates vary; not every parcel is inspected
International information and operationsINTERPOL and WHO Member State MechanismEnforcement coordination and information sharingNeither body grants product approval or universal jurisdiction
Marketplace or advertising servicePlatformCurrent listing, advertising, or storefront policyPolicies differ by platform and country; no peptide-specific removal rate was verified
PaymentPayment serviceTransactions under current terms and applicable lawA restriction does not establish medicine status or replace public enforcement
DomainRegistrar and ICANN UDRPRegistration, ownership requests, and trademark disputesDomain action does not establish product quality, legality, or medicine approval

Fake verification logos

Some peptide websites display counterfeit versions of:

  • The EU common logo for legal online pharmacies.

  • Verified Internet Pharmacy Practice Sites (VIPPS) seal (US).

  • Pharmacy logo seals of national authorities (GPhC, MHRA, etc.).

Where such seals are legally defined, unauthorised display is generally fraudulent. Enforcement and legal consequences vary by jurisdiction.

Trust mark verification
Trust mark verificationA verification logo must be checked through the official authority domain against the exact pharmacy or domain and its current register status; the image alone is not verification.LOGO IMAGEclick throughto officialauthority domaindoes the registername this exactpharmacy / domain?record +current statusIMAGE-ONLY SHORTCUTVERIFIED
This is media literacy, not purchasing guidance: verify the exact domain in the official authority register.
Alternatif teks

Logo image → official authority domain → exact pharmacy or domain in the register → record and current status. Do not take the image-only shortcut to verified.

Enforcement limitations

Four recurring limits are summarized below. They do not establish the status of a particular website, shipment, or peptide product.

Practical interpretation limits

This is general regulatory research, not legal advice. Classification can turn on composition, claims, intended use, route, supplier role, and facts not captured by a product name.

Related atlas pages: global framework, United States, EU and EEA, United Kingdom, and product quality.

Primary sources

Pertanyaan

Which country's law can apply to an online peptide sale?

There is no universal answer. As of 2026-08-06, the locations of the seller, website, payment service, dispatch, import, buyer, and claims can engage different laws and authorities.

Does a pharmacy logo prove that a website is authorized?

No. As of 2026-08-06, a logo image can be copied or misused. Follow it to the official authority domain and verify that the current register names the exact pharmacy and website domain.

What roles do INTERPOL and WCO play?

As of 2026-08-06, INTERPOL coordinates international operations against illicit online medicine activity, while WCO supports customs cooperation and tools. Neither organization grants medicine approval or has universal jurisdiction over every sale.

Can payment or domain action replace medicine enforcement?

No. Payment services and domain actors address separate control points under their terms, trademark processes, and applicable law. As of 2026-08-06, those actions do not determine medicine status or replace regulator and customs functions.